Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Fate Therapeutics (FATE) over the last 13 years, with Q3 2025 value amounting to $810000.0.

  • Fate Therapeutics' Amortizatization of Intangibles fell 6311.48% to $810000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 5930.57%. This contributed to the annual value of $9.1 million for FY2024, which is 2033.69% down from last year.
  • As of Q3 2025, Fate Therapeutics' Amortizatization of Intangibles stood at $810000.0, which was down 6311.48% from $847000.0 recorded in Q2 2025.
  • In the past 5 years, Fate Therapeutics' Amortizatization of Intangibles registered a high of $3.3 million during Q3 2023, and its lowest value of -$1.5 million during Q2 2021.
  • Moreover, its 5-year median value for Amortizatization of Intangibles was $1.1 million (2025), whereas its average is $968000.0.
  • In the last 5 years, Fate Therapeutics' Amortizatization of Intangibles tumbled by 50283.4% in 2021 and then soared by 69633.25% in 2023.
  • Over the past 5 years, Fate Therapeutics' Amortizatization of Intangibles (Quarter) stood at -$1.1 million in 2021, then skyrocketed by 216.14% to $1.2 million in 2022, then soared by 133.41% to $2.9 million in 2023, then plummeted by 47.35% to $1.5 million in 2024, then tumbled by 47.06% to $810000.0 in 2025.
  • Its last three reported values are $810000.0 in Q3 2025, $847000.0 for Q2 2025, and $1.1 million during Q1 2025.